These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 30058675)
1. MiR-129 is involved in the occurrence of uterine fibroid through inhibiting TET1. Lu JL; Zhao L; Han SC; Bi JL; Liu HX; Yue C; Lin L Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4419-4426. PubMed ID: 30058675 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma. Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655 [TBL] [Abstract][Full Text] [Related]
3. Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma. Chuang TD; Khorram O Reprod Sci; 2019 Feb; 26(2):250-258. PubMed ID: 29642801 [TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells. Ling J; Wu X; Fu Z; Tan J; Xu Q Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392 [TBL] [Abstract][Full Text] [Related]
5. From 2646 to 15: differentially regulated microRNAs between progenitors from normal myometrium and leiomyoma. Lazzarini R; Caffarini M; Delli Carpini G; Ciavattini A; Di Primio R; Orciani M Am J Obstet Gynecol; 2020 Jun; 222(6):596.e1-596.e9. PubMed ID: 31874141 [TBL] [Abstract][Full Text] [Related]
6. A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas. Delaney MA; Wan YW; Kim GE; Creighton CJ; Taylor MG; Masand R; Park A; Valdes C; Gibbons W; Liu Z; Anderson ML J Clin Endocrinol Metab; 2017 Sep; 102(9):3316-3326. PubMed ID: 28637297 [TBL] [Abstract][Full Text] [Related]
7. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p. Yang E; Xue L; Li Z; Yi T BMC Cancer; 2019 Jul; 19(1):709. PubMed ID: 31319799 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma. Qiang W; Liu Z; Serna VA; Druschitz SA; Liu Y; Espona-Fiedler M; Wei JJ; Kurita T Endocrinology; 2014 Mar; 155(3):663-9. PubMed ID: 24424054 [TBL] [Abstract][Full Text] [Related]
9. Effects of miRNA-197 overexpression on proliferation, apoptosis and migration in levonorgestrel treated uterine leiomyoma cells. Wu X; Ling J; Fu Z; Ji C; Wu J; Xu Q Biomed Pharmacother; 2015 Apr; 71():1-6. PubMed ID: 25960207 [TBL] [Abstract][Full Text] [Related]
10. MiR-365a-3p suppresses proliferation and invasion of Hep-2 cells through targeting ten-eleven translocation 1 (TET1). Li J; Shen N; Bai GP; Huang XS Neoplasma; 2018 Sep; 65(5):730-735. PubMed ID: 30249104 [TBL] [Abstract][Full Text] [Related]
11. miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1. Liu J; Li M; Liu X; Liu F; Zhu J Int J Oncol; 2018 Apr; 52(4):1295-1304. PubMed ID: 29484426 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma. Chuang TD; Khorram O Fertil Steril; 2016 Jan; 105(1):236-45.e1. PubMed ID: 26453978 [TBL] [Abstract][Full Text] [Related]
13. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA. Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049 [TBL] [Abstract][Full Text] [Related]
14. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Chuang TD; Rehan A; Khorram O Fertil Steril; 2021 Jan; 115(1):238-247. PubMed ID: 33070965 [TBL] [Abstract][Full Text] [Related]
15. Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma. Chuang TD; Khorram O Fertil Steril; 2019 Dec; 112(6):1180-1189. PubMed ID: 31843095 [TBL] [Abstract][Full Text] [Related]
16. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells. Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262 [TBL] [Abstract][Full Text] [Related]
17. FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition. New EP; Semerci N; Ozmen A; Guo X; Jonnalagadda VA; Kim JW; Anderson ML; Guzeloglu-Kayisli O; Imudia AN; Lockwood CJ; Kayisli UA Reprod Sci; 2022 Jun; 29(6):1939-1949. PubMed ID: 35426036 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708 [TBL] [Abstract][Full Text] [Related]
19. PLIN2 Functions As a Novel Link Between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells. Okeigwe I; Bulun S; Liu S; Rademaker AW; Coon JS; Kujawa S; Robins J; Yin P J Clin Endocrinol Metab; 2019 Dec; 104(12):6256-6264. PubMed ID: 31504629 [TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]